Literature DB >> 18597156

Elevated urinary nitrite and citrulline levels in patients with rheumatoid arthritis.

A Wanchu1, M Khullar, A Sud, S D Deodhar, P Bambery.   

Abstract

The objective of this research was to determine, if NO production, as measured in the serum and urine, is increased in patients with rheumatoid arthritis. Forty-seven patients with RA were recruited in the study and subdivided into inactive and active disease (24 and 23 patients, respectively). Twenty-eight healthy individuals served as controls and nine patients with gastroenteritis were studied to validate the technique of measurement of NO production. Nitrite and citrulline were measured by spectrophotometry, as surrogate markers of NO production. It was found that serum nitrite and citrulline levels of patients with gastroenteritis were not significantly different from controls and the two subgroups of RA. Urine nitrite and citrulline levels were significantly higher in patients with gastroenteritis as compared to the two subgroups of RA and controls (p > 0.001). Serum and urine nitrite levels of patients with active RA were higher than controls and patients with inactive disease (p > 0.05). Serum citrulline levels were not significantly different among the two subgroups of patients with RA. However, they were significantly higher in patients with active disease as compared with controls (p > 0.05). Urinary citrulline levels were significantly higher among patients with active disease as compared to controls and patients with inactive RA (p > 0.05). It is therefore suggested that urinary nitrite and citrulline levels can be useful for the measurement of NO production and are associated with active disease in patients with RA.

Entities:  

Year:  1999        PMID: 18597156     DOI: 10.1007/BF02918387

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  19 in total

1.  Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  The L-arginine-nitric oxide pathway.

Authors:  S Moncada; A Higgs
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

3.  Increased serum NG-hydroxy-L-arginine in patients with rheumatoid arthritis and systemic lupus erythematosus as an index of an increased nitric oxide synthase activity.

Authors:  R Wigand; J Meyer; R Busse; M Hecker
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

4.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

5.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

6.  Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis.

Authors:  A Wanchu; S D Deodhar; M Sharma; V Gupta; P Bambery; A Sud
Journal:  Indian J Med Res       Date:  1997-01       Impact factor: 2.375

7.  Plasma reactive nitrogen intermediate levels in patients with clinically active rheumatoid arthritis.

Authors:  A Wanchu; N Agnihotri; S D Deodhar; N K Ganguly
Journal:  Indian J Med Res       Date:  1996-10       Impact factor: 2.375

8.  Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

Authors:  H Sakurai; H Kohsaka; M F Liu; H Higashiyama; Y Hirata; K Kanno; I Saito; N Miyasaka
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

9.  Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.

Authors:  A J Farrell; D R Blake; R M Palmer; S Moncada
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

10.  Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients.

Authors:  H Kaur; B Halliwell
Journal:  FEBS Lett       Date:  1994-08-15       Impact factor: 4.124

View more
  2 in total

1.  Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome.

Authors:  M Miletic; R Stojanovic; O Pajic; D Bugarski; S Mojsilovic; V Cokic; P Milenkovic
Journal:  Indian J Med Res       Date:  2012-04       Impact factor: 2.375

2.  Antitubercular therapy decreases nitric oxide production in HIV/TB coinfected patients.

Authors:  Ajay Wanchu; Archana Bhatnagar; Madhu Khullar; Archana Sud; Pradeep Bambery; Surjit Singh
Journal:  BMC Infect Dis       Date:  2002-07-29       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.